CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB VERSUS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF THE PHASE 3 CANDOR STUDY BY NUMBER OF PRIOR LINES OFTHERAPY AND PRIOR THERAPIES
Quach, H., Nooka, A., Samoylova, O., Venner, C.P., Facon, T., Spencer, A., Usmani, S.Z., Weisel, K., Mateos, M., Kim, K., Grosicki, S., Suzuki, K., Delimpasi, S., Obreja, M., Zahlten-Kumeli, A.
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Get full text
Journal Article
Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the upfront therapy of transplant ineligible patients with multiple myeloma
Venner, C.P, Bahlis, N.J, Neri P, P, Sandhu, I, Duggan, P, Belch, A.R, Hewitt, J.D, Pilarski, L.M, Nikitina, T, Jimenez-Zepeda, V
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Myeloma Canada Research Network (MCRN) 001 Trial with Intravenous (IV) Busulfan + Melphalan (BuMel) as Enhanced Conditioning, followed by Lenalidomide (Len) Maintenance in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts): First Results of Minimal Residual Disease (MRD) and Hevylite(TM) Chain (HLC) Assays at Day 100 Post Autologous Stem Cell Transplant (ASCT)
Reece, D, Rodriguez, G.P, Pantoja, M, Paul, H, Venner, C.P, White, D, Stakiw, J, Sebag, M, Comeau, T, Song, K, Roy, J, Minuk, L, Tay, J, Kukreti, V, Trudel, S, Chen, C, Tiedemann, R, Prica, A
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis
Venner, C P, Gillmore, J D, Sachchithanantham, S, Mahmood, S, Lane, T, Foard, D, Rannigan, L, Gibbs, S D J, Pinney, J H, Whelan, C J, Lachmann, H J, Hawkins, P N, Wechalekar, A D
Published in Leukemia (01.12.2014)
Published in Leukemia (01.12.2014)
Get full text
Journal Article
Renal Transplantation in Systemic Amyloidosis—Importance of Amyloid Fibril Type and Precursor Protein Abundance
Pinney, J. H., Lachmann, H. J., Sattianayagam, P. T., Gibbs, S. D. J., Wechalekar, A. D., Venner, C. P., Whelan, C. J., Gilbertson, J. A., Rowczenio, D., Hawkins, P. N., Gillmore, J. D.
Published in American journal of transplantation (01.02.2013)
Published in American journal of transplantation (01.02.2013)
Get full text
Journal Article
A matched comparison of cyclophosphamide, bortezomib and dexamethasone in AL amyloidosis
Venner, C.P, Gillmore, J.D, Sachchithanantham, S, Mahmood, S, Lane, T, Foard, D, Rannigan, L, Gibbs, S.D.J, Pinney, J.H, Whelan, C.J, Lachmann, H.J, Hawkins, P.N, Wechalekar, A.D
Published in Leukemia (01.12.2014)
Published in Leukemia (01.12.2014)
Get full text
Journal Article
PF592 IMPACT OF AGE ON EFFICACY AND SAFETY OF DARATUMUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (D‐RD) IN PATIENTS WITH TRANSPLANT‐INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): MAIA
Hulin, C., Facon, T., Kumar, S., Plesner, T., Orlowski, R.Z., Touzeau, C., Bahlis, N., Basu, S., Nahi, H., Quach, H., Goldschmidt, H., O’Dwyer, M., Cook, G., Garderet, L., Venner, C.P., Weisel, K., Raje, N., Hebraud, B., Belhadj‐Merzoug, K., Benboubker, L., Decaux, O., Manier, S., Caillot, D., Chiu, C., Krevvata, M., Wang, J., Van Rampelbergh, R., Uhlar, C., Kobos, R., Qi, M., Usmani, S.Z.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
THU0379 A 20 year single centre experience of aa amyloidosis demonstrating changes in its epidemiology
Lachmann, H.J., Gillmore, J.D., Wechalekar, A.D., Gibbs, S.D., Pinney, J.H., Rowczenio, D.M., Trojer, H., Lane, T., Venner, C.P., Banypersad, S.M., Gilbertson, J.A., Hunt, F.T., Gopaul, D., Hutt, D.F., Wassef, N., Pepys, M.B., Hawkins, P.N.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article